Sign in →

Test Code LABFHST MVista Histoplasma Ag Quantitative EIA

Additional Codes

Test Name in EPIC EPIC Test Code Mnemonic Mayo Test ID
MVista Histoplasma Ag Quantitative EIA LABFHST FHST FHST

 

Reporting Name

MVista Histoplasma Antigen

Performing Laboratory

MiraVista Diagnostics

Specimen Type

Varies


Specimen Required


Submit only 1 of the following specimens:

 

Bronchial Washing

Collect 2 mL of Bronchial Washing in leak proofed container.

Ship refrigerate.

 

Required:

1.      Label specimen appropriately (Bronchial Washing)

  

Body Fluid

Collect 2 mL of Body Fluid in leak proofed container.

Ship refrigerate.

 

Required:

1.       Label specimen appropriately (Type of Body Fluid)

 

Note: MiraVista will test most body fluids with the following disclaimer: The reference range and other method performance specifications have not been established for this test in this type of Body Fluid. The test results should be integrated into the clinical context for interpretation.

 

Note:  Minimum volume does not allow for repeats.


Specimen Minimum Volume

0.5 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Varies Refrigerated (preferred) 14 days
  Ambient  14 days
  Frozen 

Reference Values

Reference interval: None Detected

 

Reportable Range: Positive Results reported in ng/mL from 0.20 ng/mL to 20.00 ng/mL

 

Positive Results above 20.00 ng/mL are reported as “Above the Limit of Quantification”.

 

Day(s) Performed

Monday through Friday

CPT Code Information

87385

LOINC Code Information

Test ID Test Order Name Order LOINC Value
FHST MVista Histoplasma Antigen 57766-8

 

Result ID Test Result Name Result LOINC Value
Z1746 Specimen Type 31208-2
Z1747 Result 57766-8
Z1748 Interpretation 59464-8

Report Available

3 to 5 days

Reject Due To

Other Specimen that is too viscous to pipette. Tissue, biopsy, sputum, bronchial brush, tracheal aspirate, FNA, bone marrow aspirate, stool or samples in transport media, fixative or Isolator tubes

Test Classification

This test was developed and its performance characteristics determined by MiraVista Diagnostics. It has not been cleared or approved by the FDA; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Method Name

Quantitative Sandwich Enzyme Immunoassay (EIA)

Cautions

Cross-reactions are seen with blastomycosis, paracoccidioidomycosis, penicilliosis, less frequently in coccidioidomycosis, rarely in aspergillosis and possibly sporotrichosis.

Sputolysin, sodium hydroxide and potassium hydroxide treatment degrade the analyte detected in the assay.